Home LiteratureArticle Details
PMID: 8818892 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.

Journal of clinical microbiology ·Vol. 34 ·No. 8 ·1996-08-00 ·Pages 1970-4

Zerva L, Biedenbach DJ, Jones RN

Abstract

A collection of 300 Haemophilus influenzae clinical strains was used to assess in vitro susceptibility to carbapenems (meropenem, imipenem) by MIC and disk diffusion methods and to compare disk diffusion test results with two potencies of ampicillin disks (2 and 10 micrograms). The isolates included ampicillin-susceptible or- intermediate (167 strains), beta-lactamase-positive (117 strains), and beta-lactamase-negative ampicillin-resistant (BLNAR; 16 strains) organisms. Disk diffusion testing was performed with 10-micrograms meropenem disks from two manufacturers. Meropenem was highly active against H. influenzae strains (MIC50, 0.06 microgram/ml; MIC90, 0.25 microgram/ml; MIC50 and MIC90, MICs at which 50 and 90%, respectively, of strains are inhibited) and was 8- to 16-fold more potent than imipenem (MIC50, 1 microgram/ml; MIC90, 2 micrograms/ml). Five non-imipenem-susceptible strains were identified (MIC, 8 micrograms/ml), but the disk diffusion test indicated susceptibility (zone diameters, 18 to 21 mm). MIC values of meropenem, doxycycline, ceftazidime, and ceftriaxone for BLNAR strains were two- to fourfold greater than those for other strains. The performance of both meropenem disks was comparable and considered acceptable. A single susceptible interpretive zone diameter of > or = 17 mm (MIC, < = or 4 micrograms/ml) was proposed for meropenem. Testing with the 2-micrograms ampicillin disk was preferred because of an excellent correlation between MIC values and zone diameters (r = 0.94) and superior interpretive accuracy with the susceptible criteria at > or = 17 mm (MIC, < or = 1 microgram/ml) and the resistant criteria at < or = 13 mm (MIC, > or = 4 micrograms/ml). Among the BLNAR strains tested, 81.3% were miscategorized as susceptible or intermediate when the 10-micrograms ampicillin disk was used, while the 2-micrograms disk produced only minor interpretive errors (12.5%). Use of these criteria for testing H. influenzae against meropenem and ampicillin should maximize reference test and standardized disk diffusion test performance with the Haemophilus Test Medium. The imipenem disk diffusion test appears compromised and should be used with caution for detecting strains for which imipenem MICs are elevated.

MeSH Terms
Ampicillin/pharmacology Ampicillin Resistance Anti-Bacterial Agents/pharmacology Data Interpretation, Statistical Diffusion Evaluation Studies as Topic Haemophilus influenzae/drug effects Imipenem/pharmacology Linear Models Meropenem Microbial Sensitivity Tests/standards Thienamycins/pharmacology beta-Lactam Resistance
Chemicals
Anti-Bacterial Agents Thienamycins Imipenem Ampicillin Meropenem
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Zerva L
Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA.
Biedenbach D J
Jones R N
References (27)
27 references, click to expand
  1. Review of the in vitro spectrum of activity of imipenem.
    Am J Med. 1985 Jun 7;78(6A):22-32 PMID: 3890537
  2. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.
    J Antimicrob Chemother. 1995 Jul;36(1):53-64 PMID: 8537284
  3. Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae.
    J Clin Microbiol. 1987 Sep;25(9):1675-8 PMID: 3498738
  4. Detection of ampicillin resistant Haemophilus influenzae in United Kingdom laboratories.
    J Clin Pathol. 1988 Jul;41(7):716-9 PMID: 3045158
  5. The pharmacokinetics of meropenem in surgical patients with moderate or severe infections.
    J Antimicrob Chemother. 1995 Jul;36(1):165-72 PMID: 8537263
  6. A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates.
    Diagn Microbiol Infect Dis. 1995 Apr;21(4):223-5 PMID: 7554806
  7. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Drugs. 1995 Jul;50(1):73-101 PMID: 7588092
  8. Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children.
    Antimicrob Agents Chemother. 1995 Aug;39(8):1721-5 PMID: 7486908
  9. Haemophilus influenzae: then and now.
    Eur J Clin Microbiol Infect Dis. 1995 Nov;14(11):935-48 PMID: 8654443
  10. Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.
    Drugs. 1996 Jan;51(1):99-136 PMID: 8741235
  11. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
    J Antimicrob Chemother. 1989 Sep;24 Suppl A:175-81 PMID: 2808206
  12. In-vitro studies of meropenem.
    J Antimicrob Chemother. 1989 Sep;24 Suppl A:9-29 PMID: 2808218
  13. Disk diffusion susceptibility testing of Haemophilus influenzae using haemophilus test medium.
    Eur J Clin Microbiol Infect Dis. 1990 May;9(5):329-36 PMID: 2373087
  14. Problems with current recommendations for susceptibility testing of Haemophilus influenzae.
    Antimicrob Agents Chemother. 1990 Aug;34(8):1480-4 PMID: 2221855
  15. Selection and transformation of non-beta-lactamase-mediated insusceptibility to beta-lactams in Haemophilus influenzae: lack of cross-resistance between carbapenems and other agents.
    J Antimicrob Chemother. 1990 Dec;26(6):741-7 PMID: 2081716
  16. Reproducibility of disc susceptibility tests with Haemophilus influenzae.
    J Antimicrob Chemother. 1991 Mar;27(3):295-301 PMID: 2037535
  17. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.
    Antimicrob Agents Chemother. 1991 Mar;35(3):600-2 PMID: 2039214
  18. Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
    Diagn Microbiol Infect Dis. 1992 Feb;15(2):145-50 PMID: 1315231
  19. Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991.
    J Antimicrob Chemother. 1992 May;29(5):547-54 PMID: 1624392
  20. Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines.
    J Clin Microbiol. 1992 Jul;30(7):1674-7 PMID: 1629320
  21. In vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations.
    J Clin Microbiol. 1992 Dec;30(12):3035-8 PMID: 1452681
  22. Beta-lactam susceptibility of Haemophilus influenzae strains showing reduced susceptibility to cefuroxime.
    J Antimicrob Chemother. 1993 Aug;32(2):239-46 PMID: 8226426
  23. Comparative in-vitro activity of biapenem and other carbapenems against Haemophilus influenzae isolates with known resistance mechanisms to ampicillin.
    J Antimicrob Chemother. 1994 Apr;33(4):861-5 PMID: 8056706
  24. Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges.
    J Antimicrob Chemother. 1994 Jul;34(1):175-9 PMID: 7961206
  25. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group.
    Antimicrob Agents Chemother. 1994 Jul;38(7):1678-80 PMID: 7979309
  26. Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1.
    J Clin Microbiol. 1995 Jun;33(6):1665-7 PMID: 7650211
  27. Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing.
    Antimicrob Agents Chemother. 1986 Aug;30(2):274-80 PMID: 3490217
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
1996-08-00
Pages
1970-4
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC229164
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com